The continuing saga of complement receptor type 3 (CR3)

被引：38
作者：
Todd, RF
机构：
来源：
JOURNAL OF CLINICAL INVESTIGATION | 1996年 / 98卷 / 01期
关键词：
D O I：
10.1172/JCI118752
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 6 条
[1]  
ARNAOUT MA, 1990, BLOOD, V75, P1037
[2]   THE I-DOMAIN IS A MAJOR RECOGNITION SITE ON THE LEUKOCYTE INTEGRIN MAC-1 (CD11B/CD18) FOR 4 DISTINCT ADHESION LIGANDS [J].
DIAMOND, MS ;
GARCIAAGUILAR, J ;
BICKFORD, JK ;
CORBI, AL ;
SPRINGER, TA .
JOURNAL OF CELL BIOLOGY, 1993, 120 (04) :1031-1043
[3]   Integrins as promiscuous signal transduction devices [J].
Petty, HR ;
Todd, RF .
IMMUNOLOGY TODAY, 1996, 17 (05) :209-212
[4]   SPECIFICITY OF MEMBRANE COMPLEMENT RECEPTOR TYPE 3 (CR3) FOR BETA-GLUCANS [J].
ROSS, GD ;
CAIN, JA ;
MYONES, BL ;
NEWMAN, SL ;
LACHMANN, PJ .
COMPLEMENT, 1987, 4 (02) :61-74
[5]  
Thornton BP, 1996, J IMMUNOL, V156, P1235
[6]   Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells [J].
Vetvicka, V ;
Thornton, BP ;
Ross, GD .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (01) :50-61
1